The latest liver disease news, facts about liver damage, liver failure and liver disease information.
Wednesday, November 28, 2007
GSK to sell Merck's OTC lovastatin in US (PharmaBiz)
GlaxoSmithKline plc said it acquired the rights to sell over-the-counter (OTC) marketing rights of Merck's cholesterol lowering drug Mevacor (lovastatin) in the US.
No comments:
New comments are not allowed.